← Open Payments lookup

KIMBERLY KALOVCAK: Open Payments

NPI 1942772405 · POTTSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,258 in 64 payments from 15 companies in 2025. Trend: 2023 $1,697 · 2024 $2,601 · 2025 $1,258

Food & beverage: $1,258
CompanyPaymentsAmount
Janssen Biotech, Inc.10$192
ABBVIE INC.9$184
Takeda Pharmaceuticals U.S.A., Inc.11$173
Ardelyx, Inc.5$142
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$111
Aimmune Therapeutics, Inc.5$82
Madrigal Pharmaceuticals3$79
Regeneron Healthcare Solutions, Inc.3$67
Celltrion USA Inc.3$60
Ferring Pharmaceuticals Inc.2$45

Products named: TREMFYA, IBSRELA, ENTYVIO, XIFAXAN, RINVOQ, DUPIXENT, ZENPEP, REZDIFFRA.

Industry payments across PA — which companies pay providers there.